Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Sequencing of glycosaminoglycans with potential to interrogate sequence-specific interactions.

van Kuppevelt TH, Oosterhof A, Versteeg EMM, Podhumljak E, van de Westerlo EMA, Daamen WF.

Sci Rep. 2017 Nov 1;7(1):14785. doi: 10.1038/s41598-017-15009-0.

2.

Evidence of ER stress and UPR activation in patients with Brody disease and Brody syndrome.

Guglielmi V, Voermans NC, Oosterhof A, Nowis D, van Engelen BG, Tomelleri G, Vattemi G.

Neuropathol Appl Neurobiol. 2018 Aug;44(5):533-536. doi: 10.1111/nan.12431. No abstract available.

PMID:
28801956
3.

The Final Fight: An Analysis of Metaphors in Online Obituaries of Professional Athletes.

Heynderickx PC, Dieltjens SM, Oosterhof A.

Omega (Westport). 2017 Jan 1:30222817715757. doi: 10.1177/0030222817715757. [Epub ahead of print]

PMID:
28631519
4.

Heparan Sulfates Support Pyramidal Cell Excitability, Synaptic Plasticity, and Context Discrimination.

Minge D, Senkov O, Kaushik R, Herde MK, Tikhobrazova O, Wulff AB, Mironov A, van Kuppevelt TH, Oosterhof A, Kochlamazashvili G, Dityatev A, Henneberger C.

Cereb Cortex. 2017 Feb 1;27(2):903-918. doi: 10.1093/cercor/bhx003.

5.

Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy.

Guglielmi V, Oosterhof A, Voermans NC, Cardani R, Molenaar JP, van Kuppevelt TH, Meola G, van Engelen BG, Tomelleri G, Vattemi G.

Neuromuscul Disord. 2016 Jun;26(6):378-85. doi: 10.1016/j.nmd.2016.04.003. Epub 2016 Apr 6.

PMID:
27133661
6.

Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma.

Heidari-Hamedani G, Vivès RR, Seffouh A, Afratis NA, Oosterhof A, van Kuppevelt TH, Karamanos NK, Metintas M, Hjerpe A, Dobra K, Szatmári T.

Cell Signal. 2015 Oct;27(10):2054-67. doi: 10.1016/j.cellsig.2015.07.017. Epub 2015 Jul 23. Erratum in: Cell Signal. 2015 Dec;27(12):2599-601.

7.

A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino)glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3).

van Wijk XM, Lawrence R, Thijssen VL, van den Broek SA, Troost R, van Scherpenzeel M, Naidu N, Oosterhof A, Griffioen AW, Lefeber DJ, van Delft FL, van Kuppevelt TH.

FASEB J. 2015 Jul;29(7):2993-3002. doi: 10.1096/fj.14-264226. Epub 2015 Apr 13.

8.

Primary ovarian carcinomas and abdominal metastasis contain 4,6-disulfated chondroitin sulfate rich regions, which provide adhesive properties to tumour cells.

Vallen MJ, Schmidt S, Oosterhof A, Bulten J, Massuger LF, van Kuppevelt TH.

PLoS One. 2014 Nov 5;9(11):e111806. doi: 10.1371/journal.pone.0111806. eCollection 2014.

9.

Distinct patterns of heparan sulphate in pancreatic islets suggest novel roles in paracrine islet regulation.

Theodoraki A, Hu Y, Poopalasundaram S, Oosterhof A, Guimond SE, Disterer P, Khoo B, Hauge-Evans AC, Jones PM, Turnbull JE, van Kuppevelt TH, Bouloux PM.

Mol Cell Endocrinol. 2015 Jan 5;399:296-310. doi: 10.1016/j.mce.2014.09.011. Epub 2014 Sep 16.

PMID:
25224485
10.

'Immunosequencing' of heparan sulfate from human cell lines and rat kidney: the (GlcNS6S-IdoA2S)₃ motif, recognized by antibody NS4F5, is located towards the non-reducing end.

van Wijk XM, Oosterhof A, Versteeg EM, van de Westerlo EM, van Kuppevelt TH.

Biochem J. 2014 Aug 1;461(3):461-8. doi: 10.1042/BJ20140355.

PMID:
24819558
11.

Interfering with UDP-GlcNAc metabolism and heparan sulfate expression using a sugar analogue reduces angiogenesis.

van Wijk XM, Thijssen VL, Lawrence R, van den Broek SA, Dona M, Naidu N, Oosterhof A, van de Westerlo EM, Kusters LJ, Khaled Y, Jokela TA, Nowak-Sliwinska P, Kremer H, Stringer SE, Griffioen AW, van Wijk E, van Delft FL, van Kuppevelt TH.

ACS Chem Biol. 2013 Oct 18;8(10):2331-8. doi: 10.1021/cb4004332. Epub 2013 Sep 3.

12.

Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains.

Dick G, Tan CL, Alves JN, Ehlert EM, Miller GM, Hsieh-Wilson LC, Sugahara K, Oosterhof A, van Kuppevelt TH, Verhaagen J, Fawcett JW, Kwok JC.

J Biol Chem. 2013 Sep 20;288(38):27384-95. doi: 10.1074/jbc.M111.310029. Epub 2013 Aug 12.

13.

SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers.

Guglielmi V, Vattemi G, Gualandi F, Voermans NC, Marini M, Scotton C, Pegoraro E, Oosterhof A, Kósa M, Zádor E, Valente EM, De Grandis D, Neri M, Codemo V, Novelli A, van Kuppevelt TH, Dallapiccola B, van Engelen BG, Ferlini A, Tomelleri G.

Mol Genet Metab. 2013 Sep-Oct;110(1-2):162-9. doi: 10.1016/j.ymgme.2013.07.015. Epub 2013 Jul 20.

PMID:
23911890
14.

HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity.

Seffouh A, Milz F, Przybylski C, Laguri C, Oosterhof A, Bourcier S, Sadir R, Dutkowski E, Daniel R, van Kuppevelt TH, Dierks T, Lortat-Jacob H, Vivès RR.

FASEB J. 2013 Jun;27(6):2431-9. doi: 10.1096/fj.12-226373. Epub 2013 Mar 1.

PMID:
23457216
15.

Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate development.

Buresh-Stiemke RA, Malinowski RL, Keil KP, Vezina CM, Oosterhof A, Van Kuppevelt TH, Marker PC.

Dev Dyn. 2012 Dec;241(12):2005-13. doi: 10.1002/dvdy.23886. Epub 2012 Nov 5.

16.

Extraction and structural analysis of glycosaminoglycans from formalin-fixed, paraffin-embedded tissues.

van Wijk XM, Vallen MJ, van de Westerlo EM, Oosterhof A, Hao W, Versteeg EM, Raben J, Wismans RG, Smetsers TF, Dijkman HB, Schalkwijk J, van Kuppevelt TH.

Glycobiology. 2012 Dec;22(12):1666-72. doi: 10.1093/glycob/cws119. Epub 2012 Aug 2.

PMID:
22859440
17.

Brody syndrome: a clinically heterogeneous entity distinct from Brody disease: a review of literature and a cross-sectional clinical study in 17 patients.

Voermans NC, Laan AE, Oosterhof A, van Kuppevelt TH, Drost G, Lammens M, Kamsteeg EJ, Scotton C, Gualandi F, Guglielmi V, van den Heuvel L, Vattemi G, van Engelen BG.

Neuromuscul Disord. 2012 Nov;22(11):944-54. doi: 10.1016/j.nmd.2012.03.012. Epub 2012 Jun 15.

PMID:
22704959
18.

SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.

Wall JS, Richey T, Stuckey A, Donnell R, Oosterhof A, van Kuppevelt TH, Smits NC, Kennel SJ.

Nucl Med Biol. 2012 Jan;39(1):65-75. doi: 10.1016/j.nucmedbio.2011.06.007. Epub 2011 Sep 29.

19.

Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.

Rao G, Ding HG, Huang W, Le D, Maxhimer JB, Oosterhof A, van Kuppevelt T, Lum H, Lewis EJ, Reddy V, Prinz RA, Xu X.

Diabetologia. 2011 Jun;54(6):1527-38. doi: 10.1007/s00125-011-2110-z. Epub 2011 Mar 20.

PMID:
21424539
20.

Differential distribution of heparan sulfate glycoforms and elevated expression of heparan sulfate biosynthetic enzyme genes in the brain of mucopolysaccharidosis IIIB mice.

McCarty DM, DiRosario J, Gulaid K, Killedar S, Oosterhof A, van Kuppevelt TH, Martin PT, Fu H.

Metab Brain Dis. 2011 Mar;26(1):9-19. doi: 10.1007/s11011-010-9230-x. Epub 2011 Jan 12.

21.

A 4-deoxy analogue of N-acetyl-D-glucosamine inhibits heparan sulphate expression and growth factor binding in vitro.

van Wijk XM, Oosterhof A, van den Broek SA, Griffioen AW, ten Dam GB, Rutjes FP, van Delft FL, van Kuppevelt TH.

Exp Cell Res. 2010 Sep 10;316(15):2504-12. doi: 10.1016/j.yexcr.2010.04.025. Epub 2010 Apr 28.

PMID:
20433828
22.

Brody disease: insights into biochemical features of SERCA1 and identification of a novel mutation.

Vattemi G, Gualandi F, Oosterhof A, Marini M, Tonin P, Rimessi P, Neri M, Guglielmi V, Russignan A, Poli C, van Kuppevelt TH, Ferlini A, Tomelleri G.

J Neuropathol Exp Neurol. 2010 Mar;69(3):246-52. doi: 10.1097/NEN.0b013e3181d0f7d5.

PMID:
20142766
23.

Are the outcomes of clinical pathways evidence-based? A critical appraisal of clinical pathway evaluation research.

El Baz N, Middel B, van Dijk JP, Oosterhof A, Boonstra PW, Reijneveld SA.

J Eval Clin Pract. 2007 Dec;13(6):920-9. Review.

PMID:
18070263
24.

Amplitude modulation of nuclear Ca2+ signals in human skeletal myotubes: a possible role for nuclear Ca2+ buffering.

Koopman WJ, Willems PH, Oosterhof A, van Kuppevelt TH, Gielen SC.

Cell Calcium. 2005 Aug;38(2):141-52.

PMID:
16054687
25.

Upregulation of Ca2+ removal in human skeletal muscle: a possible role for Ca2+-dependent priming of mitochondrial ATP synthesis.

Koopman WJ, Renders M, Oosterhof A, van Kuppevelt TH, van Engelen BG, Willems PH.

Am J Physiol Cell Physiol. 2003 Nov;285(5):C1263-9. Epub 2003 Jul 2.

26.

Halothane-induced calcium release in cultured human skeletal muscle cells from a family susceptible to malignant hyperthermia with an unidentified mutation in chromosome 19.

Snoeck MM, Oosterhof A, Tangerman A, Veerkamp JH, van Engelen BG, Gielen MJ.

Anesthesiology. 2002 Jul;97(1):272-4. No abstract available.

PMID:
12131133
27.

Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.

Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH.

J Neurosci. 2000 Jun 1;20(11):4099-111.

28.

Differentiation markers of mouse C2C12 and rat L6 myogenic cell lines and the effect of the differentiation medium.

Portiér GL, Benders AG, Oosterhof A, Veerkamp JH, van Kuppevelt TH.

In Vitro Cell Dev Biol Anim. 1999 Apr;35(4):219-27.

PMID:
10478802
29.

Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate.

Pieper JS, Oosterhof A, Dijkstra PJ, Veerkamp JH, van Kuppevelt TH.

Biomaterials. 1999 May;20(9):847-58.

PMID:
10226711
30.
31.

First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas).

Oosterwijk JC, Jansen JC, van Schothorst EM, Oosterhof AW, Devilee P, Bakker E, Zoeteweij MW, van der Mey AG.

J Med Genet. 1996 May;33(5):379-83.

32.

Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells.

Veerkamp JH, Smit JW, Benders AA, Oosterhof A.

Biochim Biophys Acta. 1996 Apr 12;1315(3):217-22.

33.

Ca2+ homeostasis in Brody's disease. A study in skeletal muscle and cultured muscle cells and the effects of dantrolene an verapamil.

Benders AA, Veerkamp JH, Oosterhof A, Jongen PJ, Bindels RJ, Smit LM, Busch HF, Wevers RA.

J Clin Invest. 1994 Aug;94(2):741-8.

34.

Deficiency of Na+/K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase in skeletal muscle and cultured muscle cells of myotonic dystrophy patients.

Benders AA, Timmermans JA, Oosterhof A, Ter Laak HJ, van Kuppevelt TH, Wevers RA, Veerkamp JH.

Biochem J. 1993 Jul 1;293 ( Pt 1):269-74.

35.

Adenosine triphosphatases during maturation of cultured human skeletal muscle cells and in adult human muscle.

Benders AG, van Kuppevelt TH, Oosterhof A, Wevers RA, Veerkamp JH.

Biochim Biophys Acta. 1992 Nov 23;1112(1):89-98.

PMID:
1329967
36.

Expression of different isoenzymes of adenylate deaminase in cultured human muscle cells. Relation to myoadenylate deaminase deficiency.

Jacobs AE, Oosterhof A, Benders AA, Veerkamp JH.

Biochim Biophys Acta. 1992 Jun 9;1139(1-2):91-5.

PMID:
1610923
38.

The biochemical and structural maturation of human skeletal muscle cells in culture: the effect of the serum substitute Ultroser G.

Benders AA, van Kuppevelt TH, Oosterhof A, Veerkamp JH.

Exp Cell Res. 1991 Aug;195(2):284-94.

PMID:
1649054
39.

Effect of various agents on the cytoplasmic calcium concentration in cultured human muscle cells.

Jacobs AE, Benders AA, Oosterhof A, Veerkamp JH, Wevers RA, Joosten EG.

Int J Biochem. 1991;23(1):93-9.

PMID:
2022300
40.

The calcium homeostasis and the membrane potential of cultured muscle cells from patients with myotonic dystrophy.

Jacobs AE, Benders AA, Oosterhof A, Veerkamp JH, van Mier P, Wevers RA, Joosten EM.

Biochim Biophys Acta. 1990 Nov 14;1096(1):14-9.

PMID:
2176547
41.

2-Deoxy-D-glucose uptake in cultured human muscle cells.

Jacobs AE, Oosterhof A, Veerkamp JH.

Biochim Biophys Acta. 1990 Mar 9;1051(3):230-6.

PMID:
2310773
42.

Purine and pyrimidine metabolism in human muscle and cultured muscle cells.

Jacobs AE, Oosterhof A, Veerkamp JH.

Biochim Biophys Acta. 1988 Jun 30;970(2):130-6.

PMID:
2838095
43.

Palmitate oxidation and some enzymes of energy metabolism in human muscles and cultured muscle cells.

Jacobs AE, Oosterhof A, Veerkamp JH.

Int J Biochem. 1987;19(11):1049-54.

PMID:
3428477
44.
45.

Immunochemical studies on the lipoteichoic acids of Bifidobacterium bifidum subsp. pennsylvanicum.

Op den Camp HJ, Peeters PA, Oosterhof A, Veerkamp JH.

J Gen Microbiol. 1985 Mar;131(3):661-8.

PMID:
2410545
46.

Test pattern for video displays and hard-copy cameras.

Gray JE, Lisk KG, Haddick DH, Harshbarger JH, Oosterhof A, Schwenker R.

Radiology. 1985 Feb;154(2):519-27.

PMID:
3966138
47.

Oxidative metabolism of cultured human skeletal muscle cells in comparison with biopsy material.

Zuurveld JG, Oosterhof A, Veerkamp JH, van Moerkerk HT.

Biochim Biophys Acta. 1985 Jan 18;844(1):1-8.

PMID:
3967049
48.

Cell surface hydrophobicity of Bifidobacterium bifidum subsp. pennsylvanicum.

Op den Camp HJ, Oosterhof A, Veerkamp JH.

Antonie Van Leeuwenhoek. 1985;51(3):303-12.

PMID:
4091536
49.

Interaction of bifidobacterial lipoteichoic acid with human intestinal epithelial cells.

Op den Camp HJ, Oosterhof A, Veerkamp JH.

Infect Immun. 1985 Jan;47(1):332-4.

50.

Structure of the lipoteichoic acids from Bifidobacterium bifidum spp. pennsylvanicum.

Op den Camp HJ, Veerkamp JH, Oosterhof A, Van Halbeek H.

Biochim Biophys Acta. 1984 Sep 12;795(2):301-13.

PMID:
6477947

Supplemental Content

Loading ...
Support Center